EDGE
Get a demo
Log In

Generate Biomedicines

EDGE Insights

Digital Health (Q3 2023): Funding gains momentum, GenAI dictates pace of activity
Cell and gene therapy: Repairing the building blocks of life

Recent Updates

Funding
Sep 15, 2023
Generate Biomedicines raises USD 273 million in Series C funding
AI Drug Discovery
Funding
Sep 14, 2023
Generate Biomedicines raises USD 273 million in Series C funding
Cell & Gene Therapy
Partnerships
Jan 6, 2022
Generate Biomedicines and Amgen enter into USD 1.9 billion research collaboration
AI Drug Discovery
Funding
Nov 18, 2021
Generate Biomedicines raises USD 370 million Series B
AI Drug Discovery

Company Brief


HQ location:
Somerville MA USA
Founded year:
2018
Employees:
251-500
Total Funding:
USD 693.0 million
Last Funding
USD 273.0 million, Sep 2023

Funding


Investors


No investor data is available

Funding data are powered by Crunchbase
arrow
menuarrow
Click here to learn more
Get a demo

By using this site, you agree to allow SPEEDA Edge and our partners to use cookies for analytics and personalization. Visit our privacy policy for more information about our data collection practices.